These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14738937)

  • 1. Spectrofluorimetric determination of 2-aminopyridine as a potential impurity in piroxicam and tenoxicam within the pharmacopoeial limit.
    Barary MH; Abdel-Hay MH; Sabry SM; Belal TS
    J Pharm Biomed Anal; 2004 Jan; 34(1):221-6. PubMed ID: 14738937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of tenoxicam and 2-aminopyridine using derivative spectrophotometry and high-performance liquid chromatography.
    el Walily AF; Blaih SM; Barary MH; el Sayed MA; Abdine HH; el Kersh AM
    J Pharm Biomed Anal; 1997 Aug; 15(12):1923-8. PubMed ID: 9278898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecularly imprinted polymer-based potentiometric sensor for 2-aminopyridine as a potential impurity in piroxicam.
    Najafi M; Mehdipour R
    Drug Test Anal; 2011 Feb; 3(2):132-7. PubMed ID: 21322122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect flow-injection spectrophotometric determination of meloxicam, tenoxicam and piroxicam in pharmaceutical formulations.
    Al-Momani IF
    Anal Sci; 2006 Dec; 22(12):1611-4. PubMed ID: 17159326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrophotometric and potentiometric determination of piroxicam and tenoxicam in pharmaceutical preparations.
    El-Ries MA; Mohamed G; Khalil S; El-Shall M
    Chem Pharm Bull (Tokyo); 2003 Jan; 51(1):6-10. PubMed ID: 12520119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow-injection spectrophotometric methods for the determination of tenoxicam.
    García MS; Sánchez-Pedreño C; Albero MI; Gimenez MJ
    J Pharm Biomed Anal; 1999 Dec; 21(4):731-8. PubMed ID: 10701938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrofluorimetric determination of piroxicam in the presence and absence of beta-cyclodextrin.
    Escandar GM
    Analyst; 1999 Apr; 124(4):587-91. PubMed ID: 10605882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrophotometric determination of piroxicam and tenoxicam in pharmaceutical formulations using alizarin.
    Amin AS
    J Pharm Biomed Anal; 2002 Jul; 29(4):729-36. PubMed ID: 12093502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast identification of selective resins for removal of genotoxic aminopyridine impurities via screening of molecularly imprinted polymer libraries.
    Kecili R; Billing J; Nivhede D; Sellergren B; Rees A; Yilmaz E
    J Chromatogr A; 2014 Apr; 1339():65-72. PubMed ID: 24661866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD-Cl).
    Taha EA; Salama NN; Fattah Lel-S
    Chem Pharm Bull (Tokyo); 2006 May; 54(5):653-8. PubMed ID: 16651760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiometric and spectrofluorimetric studies on complexation of tenoxicam with some metal ions.
    Mohamed HA; Wadood HM; Farghaly OA
    J Pharm Biomed Anal; 2002 Jun; 28(5):819-26. PubMed ID: 12039623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic analysis of piroxicam and tenoxicam in plasma, blood and buffer solution. Application to pharmacokinetic studies in small laboratory animals.
    Troconiz JI; Lopez-Bustamante LG; Fos D
    Arzneimittelforschung; 1993 Jun; 43(6):679-81. PubMed ID: 8352822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability indicating HPTLC determination of piroxicam.
    Puthli SP; Vavia PR
    J Pharm Biomed Anal; 2000 May; 22(4):673-7. PubMed ID: 10768357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polarographic behaviour of Aceclofenac, Tenoxicam and Droxicam in a methanol-water mixture.
    Acuña JA; Vázquez MD; Tascón ML; Sánchez-Batanero P
    J Pharm Biomed Anal; 2004 Sep; 36(1):157-62. PubMed ID: 15351060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry.
    Ji HY; Lee HW; Kim YH; Jeong DW; Lee HS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):214-9. PubMed ID: 16169293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Turbidimetric determination of tenoxicam using molybdophosphoric acid].
    Muraraşu AE; Mândrescu M; Dorneanu V
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):249-54. PubMed ID: 20509311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrofluorometric determination of piroxicam.
    Damiani PC; Bearzotti M; Cabezón M; Olivieri AC
    J Pharm Biomed Anal; 1998 Jun; 17(2):233-6. PubMed ID: 9638575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micelle-enhanced spectrofluorimetric determination of amlexanox in bioadhesive buccal tablets: application to content uniformity testing.
    Walash MI; Belal F; Tolba MM; Halawa MI
    Luminescence; 2015 Sep; 30(6):823-9. PubMed ID: 25611457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of formulated tenoxicam transdermal delivery systems.
    Kim T; Kang E; Chun I; Gwak H
    J Pharm Pharmacol; 2008 Jan; 60(1):135-8. PubMed ID: 18088513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact allergy to petrolatums. (III). Allergenicity prediction and pharmacopoeial requirements.
    Dooms-Goossens A; Dooms M
    Contact Dermatitis; 1983 Sep; 9(5):352-9. PubMed ID: 6226478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.